Sign In
Buy ZTS
$74.17
-1.16 (-1.54%)
At Close: Jul 22, 2026
2 Dividend Stocks to Buy With $500 and Hold Forever
06:30am, Friday, 23'rd May 2025
Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest.
Dr. Mark Stetter Elected to Zoetis Board of Directors
04:15pm, Thursday, 22'nd May 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced the election of Dr. Mark Stetter to its Board of Directors, effective as of the company's annual share
Zoetis Declares Third Quarter 2025 Dividend
04:15pm, Wednesday, 21'st May 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the third quarter of 2025. The dividend will b
Zoetis (ZTS) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 21'st May 2025
Zoetis (ZTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Think Zoetis (ZTS) Could Surge 26.18%: Read This Before Placing a Bet
11:01am, Friday, 16'th May 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Zoetis (ZTS). While the effectiveness of this highly sought-after metric is questionable, the positive
Zoetis to Participate in Upcoming Investor Conferences
08:30am, Thursday, 15'th May 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences. BNP Pari
Trade Tracker: Brenda Vingiello sells Zoetis and buys Quanta Services
01:41pm, Friday, 09'th May 2025
Brenda Vingiello, Chief Investment Officer at Sand Hill Global Advisors, joins 'Halftime Report' to detail her latest trades.
Zoetis' Q1: Market Overreaction Or Justified Drop?
12:16pm, Friday, 09'th May 2025
The market did not like Zoetis Inc. earnings despite strong growth and the evidence that Zoetis is becoming a better business. Buybacks continued throughout the quarter and Zoetis is a good example of
Zoetis: Solid Q1 Results And A Weaker Dollar Provide Support (Upgrade)
03:56pm, Thursday, 08'th May 2025
Zoetis shares have underperformed, losing 8% over the past year, but recent solid earnings and guidance suggest shares are nearer to fair value, shifting my stance from "sell" to "hold.". The company
Zoetis domestically manufactures 75% of its U.S. sales, says CEO Kristin Peck
05:36pm, Tuesday, 06'th May 2025
Kristin Peck, Zoetis CEO, joins 'Closing Bell Overtime' to talk quarterly results, the animal health sector, raising its guidance, and more.
Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript
12:48pm, Tuesday, 06'th May 2025
Zoetis Inc. (NYSE:ZTS ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Steve Frank - Vice President of Investor Relations Kristin Peck - Chief Executive Officer Wetteny J
Zoetis Q1 Earnings & Revenues Beat Estimates, '25 Outlook Raised
12:11pm, Tuesday, 06'th May 2025
ZTS reports better-than-expected first-quarter results as earnings and revenues surpass estimates. Management raises 2025 guidance.
Compared to Estimates, Zoetis (ZTS) Q1 Earnings: A Look at Key Metrics
10:35am, Tuesday, 06'th May 2025
Although the revenue and EPS for Zoetis (ZTS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
Zoetis (ZTS) Surpasses Q1 Earnings and Revenue Estimates
09:15am, Tuesday, 06'th May 2025
Zoetis (ZTS) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.38 per share a year ago.
Zoetis raises forecast for 2025 revenue, profit on weaker US dollar
08:31am, Tuesday, 06'th May 2025
Animal healthcare company Zoetis on Tuesday raised its forecasts for annual adjusted profit and revenue above Wall Street expectations, after beating first-quarter estimates, benefiting from a weak U.
